The Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than $2.5m per quarter. This data-driven, fact-based tracker will continually update based on new filings so that readers can stay up to date. Companies must file with the SEC or SEDAR to be considered for inclusion.
Thirteen companies currently qualify for inclusion, with five based in the United States and eight in Canada. On September 28th, we updated the list to reflect the FY18-Q1 financials released by Canadian Bioceutical (CSE: BCC) (OTC: CBICF). The company’s quarterly sales of C$5.11mm moved it into fifth-place among the Canadian companies. Its sales, which are entirely from its Arizona operations, grew 14% over FY17-Q4.
Visit the Public Cannabis Company Revenue Tracker to see the complete list of qualifying companies.
Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.